Evidence map›Paper›PMID 23817619›Full record

ArticleInfection and immunity2013

Immunosuppressive property within the Streptococcus pneumoniae cell wall that inhibits generation of T follicular helper, germinal center, and plasma cell response to a coimmunized heterologous protein.

Saumyaa, Swadhinya Arjunaraja, Lindsey Pujanauski, Jesus Colino, Raul M Torres, Clifford M Snapper

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Immune-responsiveness of CD4Scientific reports · 2016
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

SaumyaaDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Swadhinya Arjunaraja
Lindsey Pujanauski
Jesus Colino
Raul M Torres
Clifford M Snapper
Birla Institute of Technology and Science, Pilani · INNational Jewish Health · USUniformed Services University of the Health Sciences · US

Funding

Chemokine response in B cell development and functionR01AI052157 · NIAID · UNIVERSITY OF COLORADO DENVER · PI TORRES, RAUL MARTIN · 2002 to 2017
$5.4M
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSESR01AI049192 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SNAPPER, CLIFFORD M · 2001 to 2010
$2.9M
NIAID NIH HHS R01 AI049192NIAID NIH HHS R01 AI052157NIAID NIH HHS R01-AI052157NIAID NIH HHS R01-AI49192
6 · The paper itself

Abstract

We previously demonstrated that intact, inactivated Streptococcus pneumoniae (unencapsulated strain R36A) inhibits IgG responses to a number of coimmunized soluble antigens (Ags). In this study, we investigated the mechanism of this inhibition and whether other extracellular bacteria exhibited similar effects. No inhibition was observed if R36A was given 24 h before or after immunization with soluble chicken ovalbumin (cOVA), indicating that R36A acts transiently during the initiation of the immune response. Using transgenic cOVA-specific CD4(+) T cells, we observed that R36A had no significant effect on T-cell activation (24 h) or generation of regulatory T cells (day 7) and only a modest effect on T-cell proliferation (48 to 96 h) in response to cOVA. However, R36A mediated a significant reduction in the formation of Ag-specific splenic germinal center T follicular helper (GC Tfh) and GC B cells and antibody-secreting cells in the spleen and bone marrow in response to cOVA or cOVA conjugated to 4-hydroxy-3-nitrophenylacetyl hapten (NP-cOVA). Of note, the inhibitory effect of intact R36A on the IgG anti-cOVA response could be reproduced using R36A-derived cell walls. In contrast to R36A, neither inactivated, unencapsulated, intact Neisseria meningitidis nor Streptococcus agalactiae inhibited the OVA-specific IgG response. These results suggest a novel immunosuppressive property within the cell wall of Streptococcus pneumoniae.

Indexed as

AnimalsAntibodies, BacterialAntibody-Producing CellsBone MarrowCD4-Positive T-LymphocytesCell ProliferationCell WallForkhead Transcription FactorsGerminal CenterImmunoglobulin GImmunosuppressive AgentsLymphocyte ActivationMiceMice, Inbred BALB COvalbuminPlasma CellsAntibodies, BacterialForkhead Transcription FactorsFoxp3 protein, mouseImmunoglobulin GImmunosuppressive AgentsOvalbumin

Identifiers

PMID23817619
PMCPMC3754212
OpenAlexW2169335474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.